ArticleFrontiers in oncology2021

Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer.

Adam Luginbuhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.